Skip to main content

2 mg ETH267 Pill - yellow oval, 9mm

Pill with imprint 2 mg ETH267 is Yellow, Oval and has been identified as Doxazosin Mesylate 2 mg. It is supplied by Ethex Corporation.

Doxazosin is used in the treatment of Benign Prostatic Hyperplasia; High Blood Pressure; Raynaud's Syndrome and belongs to the drug classes alpha-adrenoreceptor antagonists, antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 2 mg ETH267

Doxazosin mesylate 2 mg 2 mg ETH267 Front
Doxazosin mesylate 2 mg 2 mg ETH267 Back
Doxazosin mesylate 2 mg 2 mg ETH267

Doxazosin Mesylate

2 mg ETH267
2 mg
9.00 mm
Prescription only
Drug Class
Alpha-adrenoreceptor antagonists, Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ethex Corporation
National Drug Code (NDC)
58177-0267 (Discontinued)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.